Maerevoet, M.; Casasnovas, O.; Cartron, G.; Morschhauser, F.; Thieblemont, C.; Bouabdallah, K.; Feugier, P.; Szablewski, V.; Becker, S.; Tilly, H.
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis. Cancers 2024, 16, 2672.
https://doi.org/10.3390/cancers16152672
AMA Style
Maerevoet M, Casasnovas O, Cartron G, Morschhauser F, Thieblemont C, Bouabdallah K, Feugier P, Szablewski V, Becker S, Tilly H.
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis. Cancers. 2024; 16(15):2672.
https://doi.org/10.3390/cancers16152672
Chicago/Turabian Style
Maerevoet, Marie, Olivier Casasnovas, Guillaume Cartron, Franck Morschhauser, Catherine Thieblemont, Kamal Bouabdallah, Pierre Feugier, Vanessa Szablewski, Stephanie Becker, and Herve Tilly.
2024. "Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis" Cancers 16, no. 15: 2672.
https://doi.org/10.3390/cancers16152672
APA Style
Maerevoet, M., Casasnovas, O., Cartron, G., Morschhauser, F., Thieblemont, C., Bouabdallah, K., Feugier, P., Szablewski, V., Becker, S., & Tilly, H.
(2024). Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis. Cancers, 16(15), 2672.
https://doi.org/10.3390/cancers16152672
